This page includes the latest FDA filings for Mirati Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | MRTX | DUNS 078870124 |
Device Company | Device | Date |
|---|---|---|
| Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2024-03-28 |
| Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2024-02-23 |
| Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2023-06-23 |
| Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2023-01-11 |
| Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2023-01-06 |
MIRATI THERAPEUTICS, INC | 2022-12-13 19:58:45 | |
| Mirati Therapeutics, Inc | KRAZATI | 2022-12-12 |
| NCAGE Code | 8HE38 | MIRATI THERAPEUTICS, INC. |
| CAGE Code | 8HE38 | MIRATI THERAPEUTICS, INC. MIRATI |
| S.A.M. Registration | 8HE38 [78870124] | MIRATI THERAPEUTICS, INC. MIRATI |
| SEC | 0001576263 | Mirati Therapeutics, Inc. of DELAWARE |